Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study

BACKGROUND: Since the recent introduction of GeneXepert for the detection of Tuberculosis (TB) drug resistance mutations in both primary resistance and acquired resistance in Zambia, little has been documented in literature on the issue of rifampicin resistance especially in the face of a high Natio...

Descripción completa

Detalles Bibliográficos
Autores principales: Masenga, Sepiso K., Mubila, Harrison, Hamooya, Benson M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610453/
https://www.ncbi.nlm.nih.gov/pubmed/28938874
http://dx.doi.org/10.1186/s12879-017-2750-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610453/
https://www.ncbi.nlm.nih.gov/pubmed/28938874
http://dx.doi.org/10.1186/s12879-017-2750-9

Ejemplares similares